Related references
Note: Only part of the references are listed.Comparison of Alternative Population Modeling Approaches for Implementing a Level A IVIVC and for Assessing the Time-Scaling Factor Using Deconvolution and Convolution-Based Methods
Roberto Gomeni et al.
AAPS JOURNAL (2020)
Development of sorafenib loaded nanoparticles to improve oral bioavailability using a quality by design approach
Sang Yeob Park et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Sorafenib: key lessons from over 10 years of experience
Bernard Escudier et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2019)
Current state and prospects of nano-delivery systems for sorafenib
Muhammad Adeeb Khan et al.
INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS (2018)
Current state and prospects of nano-delivery systems for sorafenib
Muhammad Adeeb Khan et al.
INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS (2018)
Combined proportional and additive residual error models in population pharmacokinetic modelling
Johannes H. Proost
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Exposure-Toxicity Relationship of Sorafenib in Japanese Patients with Renal Cell Carcinoma and Hepatocellular Carcinoma
Masahide Fukudo et al.
CLINICAL PHARMACOKINETICS (2014)
Sorafenib in advanced melanoma: a critical role for pharmacokinetics?
N. Pecuchet et al.
BRITISH JOURNAL OF CANCER (2012)
Drug Absorption Interactions Between Oral Targeted Anticancer Agents and PPIs: Is pH-Dependent Solubility the Achilles Heel of Targeted Therapy?
N. R. Budha et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Sorafenib exposure decreases over time in patients with hepatocellular carcinoma
Jennifer Arrondeau et al.
INVESTIGATIONAL NEW DRUGS (2012)
Variability of Sorafenib Toxicity and Exposure over Time: A Pharmacokinetic/Pharmacodynamic Analysis
Pascaline Boudou-Rouquette et al.
ONCOLOGIST (2012)
Bioequivalence of Highly Variable Drugs: A Comparison of the Newly Proposed Regulatory Approaches by FDA and EMA
Vangelis Karalis et al.
PHARMACEUTICAL RESEARCH (2012)
Population pharmacokinetic analysis of sorafenib in patients with solid tumours
Lokesh Jain et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Sorafenib A Review of its Use in Advanced Hepatocellular Carcinoma
Gillian M. Keating et al.
DRUGS (2009)
Highly variable drugs: Observations from bioequivalence data submitted to the FDA for new generic drug applications
Barbara M. Davit et al.
AAPS JOURNAL (2008)
In vitro studies are sometimes better than conventional human pharmacokinetic in vivo studies in assessing bioequivalence of immediate-release solid oral dosage forms
James E. Polli
AAPS JOURNAL (2008)
Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics
C Lathia et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Perls-speaks-NONMEM (PsN) - a Perl module for NONMEM related programming
L Lindbom et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2004)
Share Paper
